Raymond James & Associates Maravai Lifesciences Holdings, Inc. Transaction History

Raymond James & Associates

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	BUY	$12.09 - $15.0 $63,218 - $78,435	5,229 Added 32.41%	21,362 $265,000
Q1 2023 Apr 14, 2023	BUY	$12.99 - $16.48 $209,567 - $265,871	16,133 New	16,133 $226,000
Q3 2022 Oct 25, 2022	BUY	$20.6 - $30.37 $306,425 - $451,753	14,875 New	14,875 $380,000
Q4 2021 Feb 08, 2022	SELL	$35.0 - $45.94 $383,565 - $503,456	-10,959 Closed	0 $0
Q3 2021 Nov 02, 2021	BUY	$36.8 - $60.62 $17,259 - $28,430	469 Added 4.47%	10,959 $538,000

Q2 2021 Aug 11, 2021	SELL	$32.46 - $45.0 $1,947 - $2,700	-60 Reduced 0.57%	10,490 $438,000
Q1 2021 May 14, 2021	BUY	$25.8 - $38.49 $272,190 - $406,069	10,550 New	10,550 $376,000

227

135M

339K

148K

Ticker MRVI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 131,540,000
Market Cap $919M
Description
Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.